PHI with Infantile eczema (ongoing treatment)
How does this condition affect your private health insurance?
Infantile eczema, or atopic dermatitis, is a common chronic inflammatory skin condition typically emerging in infants between 3-6 months. It manifests as intensely itchy, red, dry, and scaly patches, frequently on the face, scalp, and extensor surfaces. This relentless itching disrupts sleep and can cause significant distress for both infant and parents. The condition stems from a compromised skin barrier and an overactive immune response, often with a genetic predisposition and associations with other allergies. While many children outgrow it, it can persist. "Ongoing treatment" aims to manage flares, reduce symptoms, and prevent complications like infections through consistent moisturizing, topical medications, and trigger avoidance.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 25%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically days to several weeks for an initial flare, depending on severity and response to treatment.
Duration of Illness (Lifetime)
Chronic, often with periods of remission and flares; many children outgrow it by school age, but it can persist or recur into adulthood.
Cost of Treatment (Initial)
Moderate, ranging from several hundred to a few thousand USD for initial diagnosis, specialist visits, and prescription medications for a flare.
Cost of Treatment (Lifetime)
Significant, potentially thousands to tens of thousands USD over a lifetime, encompassing ongoing doctor visits, topical and oral medications, specialized skincare products, and potential allergy testing.
Mortality Rate
Extremely low; death is not directly caused by eczema, though severe, untreated secondary infections could rarely lead to serious complications.
Risk of Secondary Damages
High. Includes secondary bacterial or viral skin infections (e.g., eczema herpeticum), lichenification from chronic scratching, sleep disturbances, and psychological impacts such as anxiety, poor self-esteem, or parental stress.
Probability of Full Recovery
Moderate to high (50-70% of children with infantile eczema experience remission by school age), although some may experience recurrence or persistence into adulthood.
Underlying Disease Risk
High. Often associated with other atopic conditions, including asthma, allergic rhinitis (hay fever), and food allergies, a phenomenon commonly referred to as the 'atopic march'.